Literature DB >> 22649441

Withholding breast milk for HIV exposed infants in sub-Saharan Africa: benefit or harm?

J Musa1.   

Abstract

Feeding options for HIV exposed infants has remained topical and controversial in most settings of sub-Saharan Africa. This commentary, expresses the author's opinions on this topical issue for and against breastfeeding or infant formula, with supporting evidence drawn from relevant literature on researches conducted in settings of sub-Saharan Africa. At the moment, it seems sensible to recommend that health care workers and policy makers should explore the options of making breastfeeding safer rather than withholding it for sub-Saharan African HIV exposed infants. It is hoped that when Highly Active Antiretroviral Therapy (HAART) becomes universally accessible and available to HIV infected women in sub-Saharan Africa, breast milk HIV transmission will be a rare event and the health benefits of breastfeeding for the infant and mother will be maximized.

Entities:  

Keywords:  HIV; Infant feeding; benefits; sub-Saharan Africa

Mesh:

Year:  2011        PMID: 22649441      PMCID: PMC3362971     

Source DB:  PubMed          Journal:  Afr Health Sci        ISSN: 1680-6905            Impact factor:   0.927


  7 in total

Review 1.  Infant feeding and HIV-1 infection.

Authors:  A Nicoll; M L Newell; C Peckham; C Luo; F Savage
Journal:  AIDS       Date:  2000       Impact factor: 4.177

2.  Morbidity and mortality in breastfed and formula-fed infants of HIV-1-infected women: A randomized clinical trial.

Authors:  D Mbori-Ngacha; R Nduati; G John; M Reilly; B Richardson; A Mwatha; J Ndinya-Achola; J Bwayo; J Kreiss
Journal:  JAMA       Date:  2001-11-21       Impact factor: 56.272

3.  Effect of breastfeeding on infant and child mortality due to infectious diseases in less developed countries: a pooled analysis. WHO Collaborative Study Team on the Role of Breastfeeding on the Prevention of Infant Mortality.

Authors: 
Journal:  Lancet       Date:  2000-02-05       Impact factor: 79.321

4.  Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.

Authors:  Ibou Thior; Shahin Lockman; Laura M Smeaton; Roger L Shapiro; Carolyn Wester; S Jody Heymann; Peter B Gilbert; Lisa Stevens; Trevor Peter; Soyeon Kim; Erik van Widenfelt; Claire Moffat; Patrick Ndase; Peter Arimi; Poloko Kebaabetswe; Patson Mazonde; Joseph Makhema; Kenneth McIntosh; Vladimir Novitsky; Tun-Hou Lee; Richard Marlink; Stephen Lagakos; Max Essex
Journal:  JAMA       Date:  2006-08-16       Impact factor: 56.272

5.  Risk factors for early and late transmission of HIV via breast-feeding among infants born to HIV-infected women in a randomized clinical trial in Botswana.

Authors:  Roger L Shapiro; Laura Smeaton; Shahin Lockman; Ibou Thior; Raabya Rossenkhan; Carolyn Wester; Lisa Stevens; Claire Moffat; Peter Arimi; Patrick Ndase; Aida Asmelash; Jean Leidner; Vladimir Novitsky; Joseph Makhema; Max Essex
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

6.  Effects of early, abrupt weaning on HIV-free survival of children in Zambia.

Authors:  Louise Kuhn; Grace M Aldrovandi; Moses Sinkala; Chipepo Kankasa; Katherine Semrau; Mwiya Mwiya; Prisca Kasonde; Nancy Scott; Cheswa Vwalika; Jan Walter; Marc Bulterys; Wei-Yann Tsai; Donald M Thea
Journal:  N Engl J Med       Date:  2008-06-04       Impact factor: 91.245

7.  Postnatal transmission of HIV-1 after a maternal short-course zidovudine peripartum regimen in West Africa.

Authors:  Valériane Leroy; John M Karon; Ahmadou Alioum; Ehounou R Ekpini; Philippe van de Perre; Alan E Greenberg; Philippe Msellati; Michael Hudgens; François Dabis; Stefan Z Wiktor
Journal:  AIDS       Date:  2003-07-04       Impact factor: 4.177

  7 in total
  1 in total

1.  Putting back basic sciences, political economy and sexuality into health.

Authors:  James K Tumwine
Journal:  Afr Health Sci       Date:  2011-12       Impact factor: 0.927

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.